ProCE Banner Activity

Overview, Rationale, and Guidance on Testing for Rare Genomic Alterations in Advanced Thyroid Cancer

Slideset Download
Download these slides from a live symposium at ASCP 2022 featuring guidance from a pathologist on best practices for biomarker testing in advanced thyroid cancer along with the latest clinical evidence on targeted therapies available for the treatment of RET-altered and BRAF V600E–positive disease.

Released: September 13, 2022

Begin Activity

Share

Faculty

Juan C. Hernandez-Prera

Juan C. Hernandez-Prera, MD

Associate Member
Department of Pathology
Section Head

Head & Neck - Endocrine Pathology
Department of Pathology
Moffitt Cancer Center
Tampa, Florida

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Partners

ASCP -Clinical Pathology

ProCE Banner

Faculty Disclosure

Primary Author

Juan C. Hernandez-Prera, MD

Associate Member
Department of Pathology
Section Head

Head & Neck - Endocrine Pathology
Department of Pathology
Moffitt Cancer Center
Tampa, Florida

Juan C. Hernandez-Prera, MD, has no relevant conflicts of interest to report.